Cancer biomarker Market Outlook: Diagnostics and Therapeutics
The Cancer biomarker Market spans both diagnostics and therapeutics. Diagnostic biomarkers aid in early detection and monitoring, while therapeutic biomarkers guide treatment selection.
As oncology shifts toward precision medicine, biomarkers are central to bridging diagnosis and treatment, ensuring patients receive the right therapy at the right time. This dual role is driving steady adoption worldwide.
Market Outlook: The global market size was USD 15.9 billion in 2022 and is projected to hit USD 27.8 billion by 2030, at a 9.8% CAGR.
2 Views